Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.00
+0.04 (0.45%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 303.23 | 68.56 | 74.21 | 86.18 | 1,616 | 1,095 |
Revenue Growth | 1495.93% | -7.61% | -13.89% | -94.67% | 47.50% | 1334.39% |
Gross Profit Gross Profit Growth | - | 68.53 | 73.36 | 83.42 | 1,469 | 1,030 |
Operating Income Operating Income Growth | -280.19 | -479.33 | -587.17 | -684.31 | 833.07 | 420.75 |
Net Income Net Income Growth | -251.68 | -437.99 | -521.96 | -615.06 | 515.84 | 528.58 |
Earnings Per Share EPS Growth | -1.86 | -3.16 | -3.83 | -4.59 | 3.83 | 3.96 |
EPS Growth | - | - | - | - | -3.28% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 239.91 | 2.04 | 11.53 | 47.14 | 39.7 | 1,095 |
Foreign Foreign Growth | 63.31 | 66.52 | 62.68 | 39.04 | 1,576 | - |
Total Total Growth | 303.23 | 68.56 | 74.21 | 86.18 | 1,616 | 1,095 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 532.73 | 467.02 | 905.35 | 1,522 | 2,402 | 708.15 |
Total Debt Total Debt Growth | 84.14 | 89.05 | 90.14 | 111.67 | 123.84 | 133.56 |
Net Cash (Debt) Net Cash Growth | 448.59 | 377.96 | 815.21 | 1,411 | 2,278 | 574.58 |
Net Cash Growth | -12.49% | -53.64% | -42.21% | -38.08% | 296.50% | -14.28% |
Net Cash Per Share Net Cash Per Share Growth | 3.02 | 2.73 | 5.98 | 10.52 | 16.90 | 4.31 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -202.51 | -391.78 | -446.35 | -778.79 | 1,663 | -47.59 |
Capital Expenditures CapEx Growth | -0.42 | -4.83 | -7.3 | -21.57 | -68.01 | -21.82 |
Free Cash Flow Free Cash Flow Growth | -202.93 | -396.61 | -453.65 | -800.36 | 1,595 | -69.41 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 100.00% | 99.96% | 98.86% | 96.79% | 90.94% | 93.99% |
Operating Margin | -92.40% | -699.18% | -791.27% | -794.04% | 51.56% | 38.41% |
Pretax Margin | -82.87% | -638.56% | -704.95% | -728.93% | 46.68% | 50.19% |
Profit Margin | -83.00% | -638.88% | -703.40% | -713.76% | 31.92% | 48.25% |
FCF Margin | -66.92% | -578.52% | -611.35% | -928.71% | 98.73% | -6.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 6.61 | 10.57 |
Forward PE | - | 92.73 | 92.73 | 92.73 | 92.73 | 18.86 |
P/FCF Ratio | - | - | - | - | 2.11 | - |
PS Ratio | 5.02 | 12.27 | 13.55 | 15.73 | 2.09 | 5.01 |